Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022128

Expand all

SELZENTRY (MARAVIROC)
25MG
Marketing Status: Prescription
Active Ingredient: MARAVIROC
Proprietary Name: SELZENTRY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022128
Product Number: 003
Approval Date: Nov 4, 2016
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information
SELZENTRY (MARAVIROC)
75MG
Marketing Status: Prescription
Active Ingredient: MARAVIROC
Proprietary Name: SELZENTRY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 75MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022128
Product Number: 004
Approval Date: Nov 4, 2016
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information
SELZENTRY (MARAVIROC)
150MG
Marketing Status: Prescription
Active Ingredient: MARAVIROC
Proprietary Name: SELZENTRY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022128
Product Number: 001
Approval Date: Aug 6, 2007
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information
SELZENTRY (MARAVIROC)
300MG
Marketing Status: Prescription
Active Ingredient: MARAVIROC
Proprietary Name: SELZENTRY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022128
Product Number: 002
Approval Date: Aug 6, 2007
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English